Abstract
The number of patients in the population who survived an episode of subarachnoid hemorrhage is increasing because the incidence of subarachnoid hemorrhage has remained stable and the case fatality has decreased significantly over the last decades. The number of expected life years for former patients is considerable because the mean age at which subarachnoid hemorrhage occurs is only 55 years of age. Since aneurysms develop during life and hypertension and smoking are important risk factors for subarachnoid hemorrhage, former patients are at risk of new aneurysms, new episodes of subarachnoid hemorrhage and increased risk of other cardiovascular diseases. The risk of a new episode of subarachnoid hemorrhage in survivors is 15 times higher than in the general population. The absolute risk is however only 3 % in the initial 10 years, and screening for new aneurysms is in general not efficient but should be discussed with patients with familial subarachnoid hemorrhage and in patients who had a first hemorrhage at young age (i.e. under 35–40 years of age). Persons who have survived an episode of subarachnoid hemorrhage have in the initial two decades after the hemorrhage a 1.5–2 times greater risk of death than the general population; in absolute terms, the risk of death is around 40 % after these initial two decades. The majority of causes of death are cardiovascular. Recovery of physical and cognitive deficits continues over the initial years after the hemorrhage, and beyond these initial years of recovery, quality of life continues to improve despite no further improvement in handicap. To reduce the risk of cardiovascular events, all patients should refrain from smoking and should have blood pressure properly checked and treated in case of hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Greebe P, Rinkel GJE, Hop JW, Visser-Meily JM, Algra A. Functional outcome and quality of life 5 and 12.5 years after aneurysmal subarachnoid hemorrhage. J Neurol. 2010;257(12):2059–64.
Kempen GI, Ormel J, Brilman EI, Relyveld J. Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. Am J Public Health. 1997;87(1):38–44.
Rinkel GJE, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid hemorrhage. Lancet Neurol. 2011;10(4):349–56.
Wermer MJ, Greebe P, Algra A, Rinkel GJE. Incidence of recurrent subarachnoid hemorrhage after clipping for ruptured intracranial aneurysms. Stroke. 2005;36(11):2394–9.
Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RS. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015;385(9969):691–7.
van der Schaaf IC, Velthuis BK, Wermer MJ, Majoie C, Witkamp T, de Kort G, et al. New detected aneurysms on follow-up screening in patients with previously clipped intracranial aneurysms. Comparison with DSA or CTA at the time of SAH. Stroke. 2005;36(8):1753–8.
Wermer MJ, van der Schaaf IC, Velthuis BK, Algra A, Buskens E, Rinkel GJE. Follow-up screening after subarachnoid hemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain. 2005;128:2421–9.
Wermer MJ, Greebe P, Algra A, Rinkel GJE. Long-term mortality and vascular event risk after aneurysmal subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry. 2009;80(12):1399–401.
Nieuwkamp DJ, Vaartjes I, Algra A, Rinkel GJE, Bots ML. Risk of cardiovascular events and death in the life after aneurysmal subarachnoid hemorrhage: a nationwide study. Int J Stroke. 2014;9(8):1090–6.
Nieuwkamp DJ, Algra A, Blomqvist P, Adami J, Buskens E, Koffijberg H, et al. Excess mortality and cardiovascular events in patients surviving subarachnoid hemorrhage: a nationwide study in Sweden. Stroke. 2011;42(4):902–7.
Huttunen T, Riihinen A, Pukkala E, von und zu Fraunberg M, Koivisto T, Ronkainen A, et al. Increased relative risk of lung cancer in 2,904 patients with saccular intracranial aneurysm disease in Eastern Finland. Neuroepidemiology. 2012;38(2):93–9.
Nieuwkamp DJ, de Wilde A, Wermer MJ, Algra A, Rinkel GJE. Long-term outcome after aneurysmal subarachnoid hemorrhage-risks of vascular events, death from cancer and all-cause death. J Neurol. 2014;261(2):309–15.
Huttunen T, von und zu Fraunberg M, Koivisto T, Ronkainen A, Rinne J, Sankila R, et al. Long-term excess mortality of 244 familial and 1502 sporadic one-year survivors of aneurysmal subarachnoid hemorrhage compared with a matched Eastern Finnish catchment population. Neurosurgery. 2011;68(1):20–7.
Koroknay-Pal P, Laakso A, Lehto H, Seppa K, Kivisaari R, Hernesniemi J, et al. Long-term excess mortality in pediatric patients with cerebral aneurysms. Stroke. 2012;43(8):2091–6.
Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Kaprio J. Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage. Neurology. 2013;80(5):481–6.
Greebe P, Rinkel GJE. Life expectancy after perimesencephalic subarachnoid hemorrhage. Stroke. 2007;38(4):1222–4.
Thomas AJ, Ogilvy CS. ISAT: equipoise in treatment of ruptured cerebral aneurysms? Lancet. 2015;385(9969):666–8.
Wermer MJ, Koffijberg H, van der Schaaf I. Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Neurology. 2008;70(22):2053–62.
Wermer MJ, Rinkel GJE, Greebe P, Albrecht KW, Dirven CM, Tulleken CA. Late recurrence of subarachnoid hemorrhage after treatment for ruptured aneurysms: patient characteristics and outcomes. Neurosurgery. 2005;56(2):197–204.
Bor AS, Rinkel GJE, Adami J, Koffijberg H, Ekbom A, Buskens E, et al. Risk of subarachnoid hemorrhage according to number of affected relatives: a population based case-control study. Brain. 2008;131(10):2662–5.
Bor AS, Rinkel GJE, van Norden J, Wermer MJ. Long-term, serial screening for intracranial aneurysms in individuals with a family history of aneurysmal subarachnoid hemorrhage: a cohort study. Lancet Neurol. 2014;13(4):385–92.
Bor ASE, Koffijberg H, Wermer MJ, Rinkel GJE. Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology. 2010;74(21):1671–9.
Ballard J, Kreiter KT, Claassen J, Kowalski RG, Connolly ES, Mayer SA. Risk factors for continued cigarette use after subarachnoid hemorrhage. Stroke. 2003;34(8):1859–63.
Algra AM, Klijn CJ, Helmerhorst FM, Algra A, Rinkel GJE. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology. 2012;79(12):1230–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rinkel, G.J.E., Greebe, P. (2015). Long-Term Prognosis. In: Subarachnoid Hemorrhage in Clinical Practice. In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-17840-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-17840-0_6
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17839-4
Online ISBN: 978-3-319-17840-0
eBook Packages: MedicineMedicine (R0)